Next, to determine whether CCL3 played an important role in the relationship between piR-57125 and the AKT/ERK pathway, we co-transfected ccRCC cells with piR-57125 inhibitors and CCL3 siRNAs. The gene discussed is CCL3; the disease is nonpapillary renal cell carcinoma.